Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

227 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Therapeutic application of genome editing in dyslipidemia.
Whittaker MN, Musunuru K. Whittaker MN, et al. Among authors: musunuru k. Curr Opin Lipidol. 2022 Apr 1;33(2):133-138. doi: 10.1097/MOL.0000000000000805. Curr Opin Lipidol. 2022. PMID: 34907967 Review.
Permanent alteration of PCSK9 with in vivo CRISPR-Cas9 genome editing.
Ding Q, Strong A, Patel KM, Ng SL, Gosis BS, Regan SN, Cowan CA, Rader DJ, Musunuru K. Ding Q, et al. Among authors: musunuru k. Circ Res. 2014 Aug 15;115(5):488-92. doi: 10.1161/CIRCRESAHA.115.304351. Epub 2014 Jun 10. Circ Res. 2014. PMID: 24916110 Free PMC article.
Genome editing in cardiovascular diseases.
Strong A, Musunuru K. Strong A, et al. Among authors: musunuru k. Nat Rev Cardiol. 2017 Jan;14(1):11-20. doi: 10.1038/nrcardio.2016.139. Epub 2016 Sep 9. Nat Rev Cardiol. 2017. PMID: 27609628 Review.
Genome Editing for the Study of Cardiovascular Diseases.
Chadwick AC, Musunuru K. Chadwick AC, et al. Among authors: musunuru k. Curr Cardiol Rep. 2017 Mar;19(3):22. doi: 10.1007/s11886-017-0830-5. Curr Cardiol Rep. 2017. PMID: 28220462 Free PMC article. Review.
Treatment of Dyslipidemia Using CRISPR/Cas9 Genome Editing.
Chadwick AC, Musunuru K. Chadwick AC, et al. Among authors: musunuru k. Curr Atheroscler Rep. 2017 Jul;19(7):32. doi: 10.1007/s11883-017-0668-8. Curr Atheroscler Rep. 2017. PMID: 28550381 Free PMC article. Review.
Human Germline Genome Editing.
Ormond KE, Mortlock DP, Scholes DT, Bombard Y, Brody LC, Faucett WA, Garrison NA, Hercher L, Isasi R, Middleton A, Musunuru K, Shriner D, Virani A, Young CE. Ormond KE, et al. Among authors: musunuru k. Am J Hum Genet. 2017 Aug 3;101(2):167-176. doi: 10.1016/j.ajhg.2017.06.012. Am J Hum Genet. 2017. PMID: 28777929 Free PMC article. Review.
CRISPR-Cas9 Genome Editing for Treatment of Atherogenic Dyslipidemia.
Chadwick AC, Musunuru K. Chadwick AC, et al. Among authors: musunuru k. Arterioscler Thromb Vasc Biol. 2018 Jan;38(1):12-18. doi: 10.1161/ATVBAHA.117.309326. Epub 2017 Aug 24. Arterioscler Thromb Vasc Biol. 2018. PMID: 28838920 Free PMC article. Review.
227 results